Recent Developments at Burnham Institute for Medical Research

Burnham signs agreement with Johnson & Johnson Pharmaceutical Research and Development LLC; develops a means to use search algorithms developed for the digital communications industry to identify drug combinations; identifies the molecular machinery that regulates DNA replication and the S-phase checkpoint; gets the first look at the molecular structure of the protein complex that controls apoptosis (programmed cell death).

Read the whole article on Newswise - Scinews

More from Newswise - Scinews